Premium
Comparison of salmefamol and salbutamol in patients with chronic airways obstruction.
Author(s) -
Campbell IA,
Dash CH,
McHardy GJ,
Shotter MV
Publication year - 1976
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1976.tb00582.x
Subject(s) - salbutamol , placebo , medicine , bronchodilator , anesthesia , bronchodilator agents , tachycardia , bronchodilatation , asthma , inhalation , alternative medicine , pathology
1 Inhaled salmefamol, in doses of 100 mug and 200 mug has been compared with inhaled salbutamol, in a dose of 200 mug, and with placebo in patients with airways obstruction. 2 Both salmefamol and salbutamol are potent bronchodilators with a signficantly superior action over placebo at all times up to 8 h after treatment. 3 The mean peak percentage increases in FEV produced by the three active preparations were similar. The decline from peak values was significantly slower with salmefamol than with salbutamol. Neither drug produced tachycardia.